Medicated slow release insole

Abstract

The utility model relates to a medicine slow -release insole, including insole body, the insole body bottom surface is equipped with the patch groove, this patch groove extends from the heel of insole body to the forefoot, and the bottom surface slot of patch groove is matched with the bottom plate, and the pull -out type medicine slow -release device is inserted in the mounting groove, is equipped with the cavity in the medicine slow -release device, fills the medicine in the middle part of cavity, and the slow -release material is filled around the medicine, and the medicine release channel of connecting cavity is equipped in this insertion part, the flow guide groove of extending from the mounting groove to the forefoot is equipped in the patch groove groove bottom, and the insole body is equipped with a plurality of gas guide holes that communicate with the flow guide groove. The utility model discloses the medicine slow -release device middle part filling medicine, and the four -around medicine of surrounding setting slow -release area, fills the slow -release material in the slow -release area, and slow -release material significantly reduces the medicine release speed, prolongs the sterilization deodorization time effect, guarantees the health of in -shoe hygiene, and brings the user to bring the excellent experience.

Description

Technical Field

[0001] This utility model relates to the field of insoles, and in particular to a drug-releasing insole. Background Technology

[0002] In daily life, insoles, as accessories for footwear, are mainly used to improve wearing comfort. However, traditional insoles generally lack antibacterial and deodorizing functions. With long-term use, the sweat secreted by the feet can easily breed microorganisms, which not only produce odor but may also cause foot health problems, failing to meet users' needs for a hygienic and comfortable wearing experience.

[0003] To address the aforementioned shortcomings, existing technologies have introduced insoles that claim to have antibacterial and deodorizing functions. However, these insoles rely on chemicals to achieve their antibacterial and deodorizing effects (and may also be used for other purposes). The rapid evaporation of these chemicals results in a short duration of effectiveness, making it difficult to maintain a good antibacterial and deodorizing effect over a long period and ultimately failing to meet users' actual needs for long-lasting insoles. Summary of the Invention

[0004] This invention provides a drug-releasing insole to address the problem of short duration of sterilization and deodorization of the sole in the aforementioned insoles.

[0005] The present invention adopts the following technical solution:

[0006] A drug-releasing insole includes an insole body with a patch groove on its bottom surface extending from the heel to the forefoot. A base plate is fitted to the opening of the patch groove. A rearward-facing mounting groove is formed at the heel of the patch groove. A retractable drug-releasing device is inserted into this mounting groove. The drug-releasing device has a cavity filled with a drug, surrounded by a sustained-release material. The front end of the drug-releasing device has a connector adapted to a flow channel, which provides a drug release channel connecting to the cavity. A flow channel extending from the mounting groove to the forefoot is formed at the bottom of the patch groove. The insole body has multiple air vents communicating with the flow channel.

[0007] Furthermore, the forefoot portion of the bottom of the patch groove is provided with multiple interconnected grooves, the bottom of which is provided with the aforementioned air guide hole, and the groove is connected to the aforementioned flow guide groove.

[0008] Furthermore, the aforementioned connector is provided with a plug for sealing the drug release channel, and a fragile line is pre-set between the connector and the plug for easy tearing open the drug release channel.

[0009] Furthermore, the aforementioned drug sustained-release device has a pull-out section at its rear end.

[0010] Furthermore, the material of the insole body is foam material.

[0011] Furthermore, the upper surface of the aforementioned insole body is covered with a layer of textile material.

[0012] Furthermore, the front end of the aforementioned connector is provided with a round hole for threading a rope.

[0013] As can be seen from the above description of the structure of this utility model, compared with the prior art, this utility model has the following advantages:

[0014] 1. The drug sustained-release device of this application is filled with drug in the middle of the cavity, and a sustained-release zone is set around the drug. The sustained-release zone is filled with sustained-release material. The sustained-release material significantly reduces the drug release rate, prolongs the sterilization and deodorization effect, ensures the hygiene and health of the shoe, and brings users a better experience.

[0015] 2. The drug release device of this application has an airbag structure. The drug release device can provide support and shock absorption during the stepping process, thereby improving the comfort of the insole.

[0016] 4. The insole of this application can be easily pulled out and replaced with a drug release device filled with different agents according to the user's needs (such as sterilization, deodorization or moxibustion), and the structural design is highly flexible.

[0017] 3. The insole of this application is applicable to a variety of shoe styles on the market, the sole thickness is small, the mold opening cost of the insole is low, and it can be mass-produced.

[0018] 4. The drug sustained-release device of this application can be mass-produced. The drug sustained-release device is equipped with a hanging rope and can be hung on insoles or shoes as an accessory to facilitate the promotion of its bactericidal and deodorizing effects and bring a better user experience. Attached Figure Description

[0019] Figure 1 This is a front view structural diagram of the insole of this utility model.

[0020] Figure 2 This is a rear view structural diagram of the insole of this utility model.

[0021] Figure 3 This is a schematic diagram of the split structure of the insole of this utility model.

[0022] Figure 4 This is a cross-sectional view of the insole of this utility model.

[0023] Figure 5 This is a schematic diagram of the structure of the drug sustained-release device of this utility model. Figure 1 .

[0024] Figure 6 This is a schematic diagram of the structure of the drug sustained-release device of this utility model. Figure 2 .

[0025] Figure 7 This is a cross-sectional structural diagram of the drug sustained-release device of this utility model. Detailed Implementation

[0026] The specific embodiments of this utility model are described below with reference to the accompanying drawings.

[0027] Reference Figures 1-6 A drug-releasing insole includes an insole body 1. A patch groove 10 is formed on the bottom surface of the insole body 1, extending from the heel to the forefoot. A base plate 2 is fitted to the opening of the patch groove 10, preferably made of plastic. A rearward-facing mounting groove 101 is formed at the heel of the patch groove 10. A retractable drug-releasing device 3 is inserted into the mounting groove 101. The drug-releasing device 3 has an airbag-like structure, and its outer shell is made of TPU material. A cavity 30 is provided inside the drug-releasing device 3, with a drug-filling area 301 at its center, filled with drug material. A sustained-release area 302 is provided around the drug-filling area 301, filled with a sustained-release material, which is one of a sustained-release foam, a sponge, or a sustained-release gel; in this embodiment, a sponge is preferred. The drug sustained-release device 3 has a plug-in part 31 at the front end that is adapted to the flow guide groove 102. The plug-in part 31 has a drug release channel 300 that connects to the cavity 30. The bottom of the patch groove 10 has a flow guide groove 102 that extends from the mounting groove 101 to the forefoot. The flow guide groove 102 cooperates with the bottom plate 2 to form a flow guide channel for transporting drug molecules. The insole body 1 has a plurality of air holes 11 that connect to the flow guide groove 102. The air holes 11 facilitate the flow of drug molecules to the top of the insole.

[0028] Reference Figure 3 The forefoot portion of the bottom of the aforementioned patch groove 10 is provided with multiple interconnected grooves 103, the bottom of which is provided with the aforementioned air duct 11, and the groove 103 is connected to the aforementioned flow channel 102. The middle portion of the insole body 1 is provided with multiple aforementioned air ducts 11, and the air ducts 11 in the middle portion are used to correspond to the area near the Yongquan acupoint on the sole of the foot.

[0029] Reference Figure 3 , Figure 5 The aforementioned plug portion 31 is provided with a plug head 33 for sealing the aforementioned drug release channel 300. The drug release device 3 is a closed structure before use. The plug head 33 seals the aforementioned drug release channel 300. A fragile line is pre-set between the plug portion 31 and the plug head 33 for easy tearing of the drug release channel 300. When in use, align the fragile line and tear open the drug release channel 300 so that the drug molecules can flow along the aforementioned guide groove 102 to the upper side of the insole, thereby achieving the effect of sterilization and deodorization.

[0030] The aforementioned drug sustained-release device 3 has a pull-out part 32 at its rear end. The pull-out part 32 is easy to pinch with your fingers and easily pull out the drug sustained-release device 3. The drug sustained-release device 3 can be replaced with the drug required by the user. The operation is simple and convenient.

[0031] The insole body 1 is made of foam material. The insole body 1 is elastic. When the foot steps on the insole, the drug in the drug release device 3 is crushed, and the drug molecules can be released more fully.

[0032] Reference Figure 4 The upper surface of the insole body 1 is covered with a textile material layer 12, which improves the breathability of the sole body.

[0033] Reference Figure 5 , Figure 6 The cavity 30 of the aforementioned drug sustained-release device 3 is circular, square, or triangular, preferably circular. (Refer to...) Figure 7 The cavity 30 of the drug sustained-release device 3 can also be square.

[0034] The front end of the aforementioned plug-in part 31 is provided with a round hole 310 for threading a rope, and the drug slow-release device 3 can be used as an accessory to facilitate the promotion of its antibacterial and deodorizing effects.

[0035] In addition, the drug material filled in the drug sustained-release device 3 of this utility model is not limited to antibacterial and deodorizing materials, but can also be moxibustion agents or drugs for other purposes.

[0036] The above are merely specific embodiments of this utility model, but the design concept of this utility model is not limited thereto. Any non-substantial modifications made to this utility model using this concept shall be considered as an infringement of the protection scope of this utility model.

Claims

1. A drug-releasing insole, comprising an insole body, characterized in that: The insole body has a patch groove on its bottom surface, which extends from the heel to the forefoot. The bottom opening of the patch groove is adapted to a base plate. A mounting groove with the rear opening is formed at the bottom of the patch groove. A pull-out drug release device is inserted into the mounting groove. The drug release device has a cavity, which is filled with drug. The drug is surrounded by a slow-release material. The front end of the drug release device has a connector adapted to a flow guide groove. The connector has a drug release channel connecting to the cavity. A flow guide groove extending from the mounting groove to the forefoot is formed at the bottom of the patch groove. The insole body has multiple air vents connecting to the flow guide groove.

2. The drug-releasing insole as described in claim 1, characterized in that: The front part of the bottom of the patch groove is provided with multiple interconnected grooves, and the bottom of the groove is provided with the air guide hole. The groove is connected to the flow guide groove.

3. The drug-releasing insole as described in claim 1, characterized in that: The plug portion is provided with a plug for sealing the drug release channel, and a fragile line is pre-set between the plug portion and the plug for easy tearing open the drug release channel.

4. The drug-releasing insole as described in claim 1, characterized in that: The drug sustained-release device has a pull-out section at the rear end.

5. The drug-releasing insole as described in claim 1, characterized in that: The insole body is made of foam material.

6. The drug-releasing insole as described in claim 1, characterized in that: The upper surface of the insole body is covered with a layer of textile material.

7. The drug-releasing insole as described in claim 1, characterized in that: The front end of the connector is provided with a round hole for threading a rope.

Images